This provider's $4.6M in total Medicare payments ranks in the 79th percentile of Clinical Laboratory providers nationally.
This provider's billing patterns fall within normal ranges for their specialty.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2023 | $618.93 | $400.77 | 1.54x | $218.16 | $4.6M | 11.5K | 32 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 81419 | Gene analysis panel for evaluation of genes associated with epilepsy | 298 | $715.1K | $2.4K | 1.53x |
| 81440 | Test for detecting genes | 166 | $537.7K | $3.2K | 1.53x |
| 81443 | Genomic sequence analysis panel for severe inherited conditions with sequencing of 15 or more genes | 166 | $396.1K | $2.4K | 1.53x |
| 81307 | Gene analysis (partner and localizer of brca2) full sequence analysis | 478 | $316.9K | $662.97 | 1.53x |
| 81238 | Gene analysis (coagulation factor ix) full sequence analysis | 489 | $287.5K | $588.00 | 1.53x |
| 81249 | Gene analysis (glucose-6-phosphate dehydrogenase) full sequence analysis | 487 | $286.4K | $588.00 | 1.53x |
| 81321 | Gene analysis (phosphatase and tensin homolog), full sequence analysis | 444 | $261.1K | $588.00 | 1.53x |
| 81223 | Gene analysis (cystic fibrosis transmembrane conductance regular) full gene sequence | 497 | $243.0K | $489.02 | 1.53x |
| 81334 | Gene analysis (runt related transcription factor 1) targeted sequence analysis | 495 | $159.8K | $322.92 | 1.53x |
| 81311 | Gene analysis for cancer (neuroblastoma) | 375 | $108.7K | $289.87 | 1.53x |
| 81325 | Gene analysis (peripheral myelin protein 22), full sequence analysis | 137 | $103.3K | $754.19 | 1.53x |
| 81279 | Gene analysis (janus kinase 2) targeted sequence analysis | 523 | $94.9K | $181.50 | 1.53x |
| 81339 | Gene analysis (mpl proto-oncogene, thrombopoietin receptor) sequence analysis of exon 10 | 523 | $94.9K | $181.50 | 1.53x |
| 81448 | Gene analysis panel for hereditary disorders of the peripheral nervous system | 166 | $94.8K | $570.96 | 1.53x |
| 81345 | Gene analysis (telomerase reverse transcriptase) targeted sequence analysis | 518 | $94.0K | $181.50 | 1.53x |
| 81162 | Gene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants | 26 | $46.5K | $1.8K | 1.53x |
| 81336 | Gene analysis (survival of motor neuron 1, telomeric) of full sequence | 138 | $40.8K | $295.32 | 2.02x |
| 81189 | Gene analysis (cystatin b) of full sequence | 145 | $39.1K | $269.33 | 2.06x |
| 81309 | Gene analysis (partner and localizer of brca2) targeted sequence analysis | 145 | $39.1K | $269.33 | 1.53x |
| 81236 | Gene analysis (enhancer of zeste 2 polycomb repressive complex 2 subunit) of full sequence | 138 | $38.3K | $277.22 | 1.53x |
This provider submits charges 1.54 times higher than what Medicare actually pays.
A markup ratio of 1.54x means for every $100 Medicare pays, this provider initially charges $154. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in FL for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Quest Diagnostics Clinical Laboratories Inc | Tampa, FL | $1.0B | ⚠️ Flagged |
| Laboratory Corporation Of America | Tampa, FL | $463.1M | ⚠️ Flagged |
| Quest Diagnostics Clinical Laboratories Inc | Miramar, FL | $417.1M | ⚠️ Flagged |
| American Health S, Llc | Davie, FL | $175.7M | ✓ Clear |
| Ameripath Florida Llc | Pompano Beach, FL | $80.1M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data